Haemonetics Corporation (HAE) Q3 2019 Earnings Results

Haemonetics Corporation Beats on EPS, Stock Down 12.93%

Haemonetics Corporation reported an EPS of $0.63, which was slightly above expectations. However, the stock dropped by 12.93% following the earnings announcement, indicating that investors may have had concerns beyond the EPS figure, possibly related to overall revenue performance or future outlook.

The print

Key numbers

Actual vs. consensus

Metric	Actual	Expected	Surprise
EPS	$0.63	N/A	+2.37%

Management

Management commentary

Tone: Unknown

No transcript is on record, and the analysis is based on numerical results only.

Haemonetics Corporation Beats on EPS, Stock Down 12.93%

Key numbers

Management commentary

Haemonetics Corporation

More earnings this week

Haemonetics Corporation Beats on EPS, Stock Down 12.93%

Key numbers

Management commentary